Table 6 Comparison of sensitivity and specificity of SARS-CoV 2 detection in respiratory samples using Emergency Use Authorization (EUA) PCR kits and the assay developed in this study.
This study | PowerCheck 2019-nCoV | Allplex 2019-nCoVAssay | DiaPlexQ Novel Coronavirus | STANDARD M nCoV Real-Time Detection kit | Real-Q 2019-nCoV Detection kit | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pos | Neg | Inc | Pos | Neg | Inc | Pos | Neg | Inc | Pos | Neg | Inc | Pos | Neg | Inc | ||
Pos | 54 | 53 | Â | 1* | 54 | Â | Â | 54 | Â | Â | 54 | Â | Â | 54 | Â | Â |
Neg | 50 | Â | 50 | Â | Â | 50 | Â | Â | 50 | Â | Â | 50 | Â | Â | 50 | Â |
Inc | 1 | Â | Â | 1 | Â | Â | 1 | Â | Â | 1 | Â | Â | 1 | Â | Â | 1 |
Sensitivity¶ (%) |  | 98.2 | 98.2 | 98.2 | 98.2 | 98.2 | ||||||||||
Specificity# (%) | Â | 100 | 100 | 100 | 100 | 100 | ||||||||||